Cx Institutional Charles River Laboratories International, Inc. Transaction History

Cx Institutional

$3.29 Billion
Q3 2025

A detailed history of Cx Institutional transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Cx Institutional holds 4,324 shares of CRL stock, worth $774,471. This represents 0.02% of its overall portfolio holdings.

Number of Shares

4,324

Previous 4,351 0.62%

Holding current value

$774,471

Previous $660,000 2.58%

% of portfolio

0.02%

Previous 0.02%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 23, 2025	SELL	$145.57 - $178.99 $3,930 - $4,832	-27 Reduced 0.62%	4,324 $677,000
Q2 2025 Jul 11, 2025	BUY	$99.75 - $151.89 $122,892 - $187,128	1,232 Added 39.5%	4,351 $660,000
Q1 2025 Apr 15, 2025	SELL	$150.52 - $190.14 $17,008 - $21,485	-113 Reduced 3.5%	3,119 $469,000
Q4 2024 Jan 21, 2025	SELL	$178.58 - $220.69 $20,000 - $24,717	-112 Reduced 3.35%	3,232 $596,000
Q3 2024 Oct 11, 2024	SELL	$187.96 - $245.29 $28,945 - $37,774	-154 Reduced 4.4%	3,344 $658,000
Q2 2024 Jul 11, 2024	SELL	$206.39 - $268.73 $206 - $268	-1 Reduced 0.03%	3,498 $722,000
Q1 2024 Apr 15, 2024	BUY	$203.52 - $273.43 $4,070 - $5,468	20 Added 0.57%	3,499 $948,000
Q4 2023 Jan 12, 2024	BUY	$164.52 - $238.84 $21,881 - $31,765	133 Added 3.97%	3,479 $822,000
Q3 2023 Oct 17, 2023	BUY	$194.44 - $217.61 $3,694 - $4,134	19 Added 0.57%	3,346 $655,000
Q2 2023 Jul 26, 2023	BUY	$183.71 - $210.25 $31,230 - $35,742	170 Added 5.38%	3,327 $699,000
Q1 2023 May 04, 2023	BUY	$191.89 - $259.92 $2,110 - $2,859	11 Added 0.35%	3,157 $637,000
Q4 2022 Feb 03, 2023	BUY	$197.11 - $250.07 $7,490 - $9,502	38 Added 1.22%	3,146 $685,000
Q3 2022 Nov 04, 2022	BUY	$182.44 - $250.54 $912 - $1,252	5 Added 0.16%	3,108 $612,000
Q2 2022 Aug 02, 2022	SELL	$204.13 - $302.4 $1,428 - $2,116	-7 Reduced 0.23%	3,103 $664,000
Q1 2022 May 09, 2022	BUY	$255.51 - $362.11 $511 - $724	2 Added 0.06%	3,110 $883,000
Q4 2021 Jan 18, 2022	BUY	$351.38 - $448.68 $702 - $897	2 Added 0.06%	3,108 $1.17 Million
Q3 2021 Nov 10, 2021	SELL	$372.64 - $458.3 $745 - $916	-2 Reduced 0.06%	3,106 $1.28 Million
Q3 2020 Oct 13, 2020	BUY	$175.56 - $226.45 $175 - $226	1 Added 0.03%	3,108 $704,000
Q2 2020 Aug 06, 2020	BUY	$118.84 - $189.72 $831 - $1,328	7 Added 0.23%	3,107 $542,000
Q3 2019 Oct 10, 2019	SELL	$125.07 - $143.67 $1,750 - $2,011	-14 Reduced 0.45%	3,100 $410,000
Q2 2019 Jul 17, 2019	BUY	$123.4 - $148.55 $1,727 - $2,079	14 Added 0.45%	3,114 $442,000
Q4 2018 Jan 14, 2019	BUY	$105.09 - $137.23 $325,779 - $425,412	3,100 New	3,100 $351,000

Others Institutions Holding CRL

# of Institutions

632

Shares Held

52.8M

Call Options Held

1.42M

Put Options Held

1.42M

View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $9.11B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

More about CRL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cx Institutional, based on Form 13F filings with the SEC.

News

Stay updated on Cx Institutional with notifications on news.

Account

Cx Institutional Charles River Laboratories International, Inc. Transaction History